FDA Inspection 1175618 — Northern Illinois Blood Bank Inc.
The FDA completed an inspection of Northern Illinois Blood Bank Inc. on Jul 1, 2022 in Belvidere, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 1, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Belvidere, IL (United States)